Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology

Toxicology and Applied Pharmacology(2022)10.1016/j.taap.2022.116362Source: DataRank Database

Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology is a research paper published in Toxicology and Applied Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access40 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.98)OA: greenTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Danielle E. Hale,Ali Konieczny ORCID,Veronica D. Anderson,Claire R. Richardson,Katelyn V. Brown ORCID

Live enrichment

PubMed:36592899 PMC:PMC9840691 OpenAlex:https://openalex.org/W4313454582

National Science Foundation

Grant: ENG-2015951

National Cancer Institute

Grant: R15CA252830

National Science Foundation

Grant: 2015951

RUI: BIOPOLYMER - BIObricks POLYketide Metabolic EngineeRing platform

National Institutes of Health

Grant: 1R15CA252830-01

Combinatorial biosynthesis and metabolism studies of novel tetracenomycins

National Institutes of Health

FWCI

2.98

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9840691

publisherhttps://api.elsevier.com/content/article/PII:S0041008X22005075?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0041008X22005075?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.taap.2022.116362

Fields of Study

Cancer Treatment and PharmacologyChemotherapy-induced cardiotoxicity and mitigationCancer therapeutics and mechanisms0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Antibiotics, AntineoplasticAntineoplastic AgentsDoxorubicinHumansAnthracyclinesCardiotoxicity

Keywords

CardiotoxicityAnthracyclineDoxorubicinPharmacologyRepurposingMedicineIdarubicinChemistryChemotherapyBiologyCancerInternal medicineBreast cancerAntibiotics, AntineoplasticHumansAnthracyclinesAntineoplastic Agents

Sustainable Development Goals

SDG 3: 3. Good health